During the past decade, Beebe Health Campus conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 73 clinical trials were completed, i.e. on average, 50.7% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 62 clinical trials were completed. i.e. 103.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beebe Health Campus" #1 sponsor was "National Cancer Institute (NCI)" with 85 trials, followed by "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "SWOG Cancer Research Network" with 29 trials sponsored, "NRG Oncology" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beebe Health Campus" #1 collaborator was "National Cancer Institute (NCI)" with 111 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Beebe Health Campus" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "Beebe Health Campus" in a lesser frequency.

Most popular intervention types in "Beebe Health Campus" are "Drug" (148 trials), "Other" (131 trials), "Biological" (72 trials), "Procedure" (55 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (61 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (37 trials), "Carboplatin" (26 trials) and "Biospecimen Collection" (23 trials). Other intervention names were less common.

The vast majority of trials in "Beebe Health Campus" are 157 trials for "All" genders, 31 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Beebe Health Campus". undefined are not yet recruiting, 54 are recruiting, 97 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Beebe Health Campus, 6 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Beebe Health Campus, 5 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".